In vitro models of angiogenesis: The use of Matrigel

International Journal of Biological Markers

Volumn 14, Issue 4, 1999, Pages 243-246

  Benelli, R ^a,b   Albini, A ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b CENTRO DI BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

Anglogenesis; Differentiation; Growth factors; Invasion; Matrigel

Indexed keywords

ANTIMETASTATIC AGENT; BASIC FIBROBLAST GROWTH FACTOR; CHEMOATTRACTANT; GROWTH FACTOR; MATRIGEL; METALLOPROTEINASE; STROMELYSIN; VASCULOTROPIN;

ANGIOGENESIS; BASEMENT MEMBRANE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL INVASION; CONFERENCE PAPER; DRUG SCREENING; ENDOTHELIUM CELL; EXPERIMENTAL MODEL; HUMAN; HUMAN CELL; MICROVASCULATURE; TUMOR VASCULARIZATION;

EID: 0033380108     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.1177/172460089901400408     Document Type: Conference Paper

References (28)

1. Folkman J. Angiogenesis: Initiation and modulation. In: Nicolson and Milas, eds. Cancer invasion and metastasis: biologic and therapeutic aspects. New York: Raven Press, 1984.
2. Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989; 339: 58-61.
3. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 1992; 3: 65-71.
4. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993; 143: 401-9.
5. Chen C, Parangi S, Tolentino M, Folkman J. A strategy to discover circulating angiogenesis inhibitors generated by human tumors. Cancer Res 1995; 55: 4230-3.
6. Folkman J. Angiogenesis inhibitors generated by tumors. Mol Med 1995; 1: 120-2.
7. Albini A. Tumor and endothelial cell invasion of basement membranes. Pathol Oncol Res 1998; 4: 1-12.
8. Liotta L, Steeg P, Stetler-Stevenson W. Cancer metastasis and angiogenesis. An imbalance of positive and negative regulation. Cell 1991; 64: 327-36.
9. Risau W. Mechanisms of angiogenesis. Nature 1997; 386: 671-4.
10. Montesano R, Pepper MS, Vassalli JD, Orci L. Proteolytic balance and capillary morphogenesis in vitro. In: Steiner, Weisz, Langer, eds. Angiogenesis: Key principles-Science-Technology-Medicine. Basel: Birkauser Verlag, 1992.
11. Albini A, Barillari G, Benelli R, Gallo RC, Ensoli B. Angiogenic properties of human immunodeficiency virus type I Tat protein. Proc Natl Acad Sci (USA) 1995; 92: 4838-42.
12. Albini A, Iwamoto Y, Kleinman HK, et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987; 47: 3239-45.
13. Kleinman HK, McGarvey ML, Hassell JR, et al. Basement membranes complexes with biological activity. Biochemistry 1986; 25: 312-8.
14. Albini A, Repetto L, Carlone S, et al. Characterization of Kaposi's sarcoma-derived cell cultures from an epidemic and a classic case. Int J Oncol 1992; 1: 723-30.
15. Benelli R, Albini A, Parravicini C, et al. Isolation of spindle-shaped cell populations from primary cultures of Kaposi's sarcoma of different stage. Cancer Lett 1996; 100: 125-32.
16. Potgens AJ, Westphal HR, de Waal RM, Ruiter DJ. The role of vascular permeability factor and basic fibroblast growth factor in tumor angiogenesis. Biol Chem Hoppe Seyler 1995; 376: 57-70.
17. Dvorak HF, Detmar M, Claffey KP, Nagy JA, van de Water L, Senger DR. Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol 1995; 107: 233-5.
18. Benelli R, Adatia R, Ensoli B, Stetler-Stevenson WG, Santi L, Albini A. Inhibition of AIDS-Kaposi's sarcoma cell induced endothelial cell invasion by TIMP-2 and a synthetic peptide from the metalloproteinase propeptide: implications for an anti-angiogenic therapy. Oncol Res 1994; 6: 251-7.
19. Valente P, Fassina G, Melchori A, et al. TIMP-2 overexpression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis. Int J Cancer 1998; 75: 246-53.
20. Benelli R, Masiello L, Paglialunga G, et al. IFN-alpha inhibits Tat-induced angiogenesis. In: Guenounou, ed. HIV and cytokines. Paris: Les Editions Inserum, 1997.
21. Iurlaro M, Benelli R, Masiello L, Rosso M, Albini A. Beta interferon inhibits HIV-1 Tat induced angiogenesis; synergism with 13-cis retinoic acid. Eur J Cancer 1998; 34: 570-6.
22. Albini A, Paglieri I, Orengo G, et al. The β-core fragment ot human chorionic gonadotropin (hCG) inhibits growth of Kaposi's sarcoma-derived cells and a new immortalized Kaposi's sarcoma cell line. AIDS 1997; 11: 713-21.
23. Taraboletti G, Benelli R, Borsotti P, et al. Thrombospondin-1 inhibits Kaposi's sarcoma (KS) cell and HIV-1 Tat-induced angiogenesis and is poorly expressed in KS lesions. J Pathol 1999; 187: 76-81.
24. Albini A, Florio T, Giunciuglio D, et al. Somatostatin controls Kaposi's sarcoma tumor growth through inhibition of angiogenesis. Faseb J 1999; 13: 647-55.
25. Montesano R, Orci L, Vassalli P. In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices. J Cell Biol 1983; 97: 1648-52.
26. Schenk S, Chiquet ER, Battegay EJ. The fibrinogen globe of tenascin-C promotes basic fibroblast growth factor-induced endothelial cell elongation. Mol Biol Cell 1999; 10: 2933-43.
27. Bocci G, Danesi R, Benelli U, et al. Inhibitory effect of suramin in rat models of angiogenesis in vitro and in vivo. Cancer Chemother Pharmacol 1999; 43: 205-12.
28. Sasaki C, Passaniti A. Identification of anti-invasive but non-cytotoxic chemotherapeutic agents using the tetrazolium dye MTT to quantitate viable cells in Matrigel. Biotechniques 1998; 24: 1038-43.